B Cell dysfunction in tumor-draining lymph nodes predicts relapse in oral squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: B Cell dysfunction in tumor-draining lymph nodes predicts relapse in oral squamous cell carcinoma.
Authors: Liljeström V; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Farrajota Neves da Silva P; Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden., Bark R; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden., Elliot A; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden., Marklund L; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden.; Department of Surgical Sciences, Section of Otolaryngology and Head and Neck Surgery, Uppsala University, Uppsala, Sweden., Margolin G; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden., Kumlien Georén S; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden., Cardell LO; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden., Piersiala K; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. krzysztof.piersiala@ki.se.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden. krzysztof.piersiala@ki.se.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Nov 12; Vol. 74 (12), pp. 373. Date of Electronic Publication: 2025 Nov 12.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41222706
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: B Cell dysfunction in tumor-draining lymph nodes predicts relapse in oral squamous cell carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liljeström+V%22">Liljeström V</searchLink>; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Farrajota+Neves+da+Silva+P%22">Farrajota Neves da Silva P</searchLink>; Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Bark+R%22">Bark R</searchLink>; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Elliot+A%22">Elliot A</searchLink>; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Marklund+L%22">Marklund L</searchLink>; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden.; Department of Surgical Sciences, Section of Otolaryngology and Head and Neck Surgery, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Margolin+G%22">Margolin G</searchLink>; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Kumlien+Georén+S%22">Kumlien Georén S</searchLink>; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Cardell+LO%22">Cardell LO</searchLink>; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Piersiala+K%22">Piersiala K</searchLink>; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. krzysztof.piersiala@ki.se.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden. krzysztof.piersiala@ki.se.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2025 Nov 12; Vol. 74 (12), pp. 373. <i>Date of Electronic Publication: </i>2025 Nov 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41222706
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00262-025-04231-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 373
    Titles:
      – TitleFull: B Cell dysfunction in tumor-draining lymph nodes predicts relapse in oral squamous cell carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liljeström V
      – PersonEntity:
          Name:
            NameFull: Farrajota Neves da Silva P
      – PersonEntity:
          Name:
            NameFull: Bark R
      – PersonEntity:
          Name:
            NameFull: Elliot A
      – PersonEntity:
          Name:
            NameFull: Marklund L
      – PersonEntity:
          Name:
            NameFull: Margolin G
      – PersonEntity:
          Name:
            NameFull: Kumlien Georén S
      – PersonEntity:
          Name:
            NameFull: Cardell LO
      – PersonEntity:
          Name:
            NameFull: Piersiala K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 11
              Text: 2025 Nov 12
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0851
          Numbering:
            – Type: volume
              Value: 74
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Cancer immunology, immunotherapy : CII
              Type: main
ResultId 1